terfenadine
50679-08-8
Seldane
Ternadin
Triludan
Teldane
Allerplus
Teldanex
Terfenadina
Aldaban
Terdin
RMI 9918
Terfenadinum
Terfex
RMI-9918
Seldane (TN)
Terfenadin
MFCD00079622
NSC-665802
NSC-758627
1-(4-(tert-butyl)phenyl)-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butan-1-ol
7BA5G9Y06Q
DTXSID2023642
alpha-(p-tert-Butylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol
1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol
MDL-9918
TERFENADINE [MI]
1-Piperidinebutanol, .alpha.-[4-(1,1-dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-
TERFENADINE [INN]
TERFENADINE [JAN]
TERFENADINE [HSDB]
TERFENADINE [USAN]
TERFENADINE [VANDF]
TERFENADINE [MART.]
TERFENADINE [WHO-DD]
1-(4-tert-butylphenyl)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butan-1-ol
alpha-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol
CHEMBL17157
1-Piperidinebutanol, alpha-(4-(1,1-dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-
MLS000028499
CHEBI:9453
DTXCID503642
Terfenidine
Cyater
Terfen
TERFENADINE [EP IMPURITY]
TERFENADINE [EP MONOGRAPH]
alpha-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol
NSC665802
NCGC00016064-04
NCGC00016064-06
SMR000058260
1-(4-tert-butylphenyl)-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butan-1-ol
1-(4-(tert-Butyl)phenyl)-4-(4-(hydroxydiphenylmethyl)-piperidin-1-yl)butan-1-ol
TERFENADINE (MART.)
Terfenadinum [INN-Latin]
Terfenadina [INN-Spanish]
TERFENADINE (EP IMPURITY)
TERFENADINE (EP MONOGRAPH)
Treludan
.alpha.-(p-tert-Butylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol
MDL 9918
1-(4-tert-butylphenyl)-4-[4-[hydroxy-di(phenyl)methyl]piperidin-1-yl]butan-1-ol
1-PIPERIDINEBUTANOL, .ALPHA.-(4-(1,1-DIMETHYLETHYL)PHENYL)-4-(HYDROXYDIPHENYLMETHYL)-
alpha-(4-[1,1-Dimethylethyl]phenyl)-4-[hydroxydiphenylmethyl]-1-piperidinebutanol
BRN 5857899
HSDB 6508
RMI9918
SR-01000000104
EINECS 256-710-8
teraenadine
UNII-7BA5G9Y06Q
Daylert
Histafen
Servinin
Terfenor
Bronal
Terfed
Terfin
Trexyl
Terfenadine (JAN/USAN/INN)
Terfenor fte
Triludan fte
Terfenadine FLX
a-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-piperidinebutanol
Terfenadine,(S)
1-(4-tert-butylphenyl)-4-(4-(hydroxy-di(phenyl)methyl)piperidin-1-yl)butan-1-ol
Terfinax 60
Prestwick_460
1-(4-tert-Butylphenyl)-4-(4-(alpha-hydroxybenzhydryl)piperidino)-butan-1-ol
1-(p-tert-Butylphenyl)-4-(4'-(alpha-hydroxydiphenylmethyl)-1'-piperidyl)butanol
alpha-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperdinebutanol
Histafen 120
Terfinax 120
CAS-50679-08-8
Terfenadine [USAN:USP:INN:BAN:JAN]
Terfenadine (Standard)
Opera_ID_334
Prestwick0_000138
Prestwick1_000138
Prestwick2_000138
Prestwick3_000138
(.+/-.)-Terfenadine
T 9652
SCHEMBL5152
Lopac0_001213
Oprea1_343139
BSPBio_000216
MLS001148415
DivK1c_001011
SPBio_002155
BPBio1_000238
GTPL2608
HMS503K03
HY-B1193R
KBio1_001011
R06AX12
NINDS_001011
Terfenadine - Bio-X trade mark
HMS1568K18
HMS2089I14
HMS2093I11
HMS2095K18
HMS2231N07
HMS3263D08
HMS3373J07
HMS3712K18
Pharmakon1600-01503708
HY-B1193
Tox21_110295
Tox21_110296
Tox21_501213
AC-928
BDBM50017376
NSC758627
s4353
AKOS015962091
Tox21_110295_1
CCG-205287
CS-4800
DB00342
FD28043
LP01213
NSC 665802
NSC 758627
SDCCGSBI-0051180.P004
1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butan-1-ol
1-[4-(1,1-dimethylethyl)phenyl]-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butan-1-ol
IDI1_001011
NCGC00016064-03
NCGC00016064-05
NCGC00016064-08
NCGC00016064-09
NCGC00016064-12
NCGC00016064-19
NCGC00089746-02
NCGC00089746-03
NCGC00089746-04
NCGC00261898-01
AC-15791
AS-75636
BT166253
NCI60_022784
SBI-0051180.P003
DB-051821
AB00052367
EU-0101213
NS00006817
SW196677-3
T3977
BIM-0051180.0001
C07463
D00521
D82079
AB00052367-16
AB00052367_17
AB00052367_18
EN300-22527913
L000888
Q417909
( inverted exclamation markA)-Terfenadine;MDL-991
SR-01000000104-2
SR-01000000104-4
SR-01000000104-7
BRD-A06352418-001-03-6
BRD-A06352418-001-15-0
BRD-A06352418-001-24-2
BRD-A06352418-001-25-9
Terfenadine, European Pharmacopoeia (EP) Reference Standard
Terfenadine, United States Pharmacopeia (USP) Reference Standard
(+/-)1-(4-tert-butylphenyl)-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butan-1-ol
(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol
.alpha.-(4-(1,1-dimethylethyl)phenyl)-4-(hydroxydiphenyl-methyl)-1-piperidine butanol
.alpha.-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol
1-(4-tert-Butyl phenyl)-4-(4-(alpha-hydroxybenzhydryl)piperidino)-butan-1-ol
1-(4-tert-Butyl-phenyl)-4-[4-(hydroxy-diphenyl-methyl)-piperidin-1-yl]-butan-1-ol
1-(4-tert-Butylphenyl)-4-(4-[hydroxy(diphenyl)methyl]-1-piperidinyl)-1-butanol #
1-(p-tert-Butylphenyl)-4-(4'-(alpha-hydroxydiphenylmethyl)-1'-piperidyl)-butanol
a-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol
alpha-(p-tert-Butylphenyl)-4-(alpha-hydroxy-alpha-phenylbenzyl)-1-piperidinebutanol
alpha-[4-(1,1-Dmethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol
1-(4-tert-Butyl-phenyl)-4-[4-(hydroxy-diphenyl-methyl)-piperidin-1-yl]-butan-1-ol(Terfenadine)
256-710-8
Solubility of 1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butan-1-ol (C32H41NO2)
The solubility of organic compounds can be influenced by various factors, including their molecular structure, polarity, and intermolecular interactions. For the compound 1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butan-1-ol, we can consider the following points:
In summary, while 1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butan-1-ol has the potential for good solubility in polar solvents due to hydrogen bonding, the presence of hydrophobic regions may limit its solubility in aqueous environments. A careful evaluation of the solvent environment is essential for practical applications.